Results 71 to 80 of about 191,162 (262)

Multi‐Target Pharmacological Mechanisms of Salvia miltiorrhiza Bunge in Metabolic Syndrome and Cardiovascular Diseases: A Comprehensive Review Based on the Theory of “Same Treatment for Different Diseases”

open access: yesPhytotherapy Research, EarlyView.
Salvia miltiorrhiza Bunge in metabolic syndrome and cardiovascular diseases: multi‐target actions on shared signaling pathways. ABSTRACT Metabolic syndrome (MetS) represents a clinical disorder characterized by the clustering of conditions including obesity, elevated blood sugar levels, and high lipid levels, which are intricately linked to the onset ...
Zhiyi Jia   +6 more
wiley   +1 more source

Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential

open access: yesPhytotherapy Research, EarlyView.
Schematic overview of bone remodeling dysregulation in osteoporosis and the multi‐target protective role of herbal therapeutics. ABSTRACT Osteoporosis is a chronic bone disease marked by reduced density and increased fracture risk. Current treatments face limitations in safety, efficacy, and long‐term adherence, prompting interest in alternative ...
Elnaz Vafadar Moradi   +5 more
wiley   +1 more source

Performance of Risk Assessment Indices for the Prediction of Postmenopausal Osteoporosis - Original Investigation [PDF]

open access: yes, 2009
Aim: The purpose of this study was to determine the performance of osteoporosis risk assessment indices in identifying women with osteoporosis who has high risk for osteoporosis and who will undergo dual energy X-ray absorptiometry (DEXA).
Sibel Ünsal Delialioğlu   +3 more
core  

Reducing unnecessary osteoporosis treatment in prostate cancer with FRAX‐BMD integration

open access: yesUroPrecision, EarlyView.
ABSTRACT Background Men on androgen deprivation therapy (ADT) for prostate cancer frequently develop osteoporosis, and up to 20% fracture within five years. The Fracture Risk Assessment Tool (FRAX) estimates 10‐year fracture probability with or without bone mineral density (BMD), but data in this population are scarce.
Takashi Kawahara   +10 more
wiley   +1 more source

Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996‐2023: An Observational Study of the Welsh Population

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews   +3 more
wiley   +1 more source

Risk factor identification and prevention of osteoporosis in the primary care setting [PDF]

open access: yes, 2006
On one of her visits, MB Borg, a 54 year old lady, showed concern about her risk of developing osteoporosis. Lately, she had been listening to a series of radio and TV programmes on this matter where particular emphasis was put on bone density scans. She
De Gabriele, Patricia
core  

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel   +5 more
wiley   +1 more source

Importance of Osteoporosis in Family History of Postmenopausal Osteoporotic Women - Original Investigation

open access: yes, 2006
Aim: Osteoporosis (OP) appears as a result of reduction in bone mass and deformation of micro structure is widely found in postmenopausal period. Research into etiologic risk factor and by taking required precautions may assist to prevent negative ...
Derya Demirbağ Kabayel   +2 more
core  

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis [PDF]

open access: yes, 2004
The aim of this study was to compare the effect of once-weekly 70 mg alendronate versus once-daily 10 mg alendronate in the treatment of postmenopausal osteoporosis. Sixty-three women with postmenopausal osteoporosis were randomly assigned to two groups.
İlker Çorapçı   +4 more
core  

Neuropathic Pain in Postmenopausal Osteoporosis Patients Effect on Sleep Quality, Quality of Life and Depression

open access: yes, 2022
Objective:In this study, our aimed was to investigate the frequency of neuropathic pain in women diagnosed with postmenopausal osteoporosis (OP), its effects on sleep quality, quality of life, depression and the relationship between these findings ...
Gülseren Dost Sürücü   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy